PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-11-19

Date Title Company
19-Nov-2024 Abivax Establishes an At-the-Market (ATM) Program on Nasdaq ABIVAX
19-Nov-2024 Paragon Health IT to Elevate Imaging as a Service Offering With Advanced Performance Monitoring and Workflow Automation AccessWire
19-Nov-2024 Owen Mumford Awarded Safety Phlebotomy and Specimen Collection Products Agreement With Premier, Inc. AccessWire
19-Nov-2024 Physiowell Approach: Personalized Care for Every Patient AccessWire
19-Nov-2024 Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year - Europe” AccessWire
19-Nov-2024 WoundZoom Announces Launch of the WoundZoom LIGHT Mobile Application for Post Acute Care AccessWire
19-Nov-2024 enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval AccessWire
19-Nov-2024 Next Gen Diagnostics Announces New York State Department of Health’s Wadsworth Center Has Joined the NGD Cefiderocol Data Consortium for the Sequencing-Based Determination of Cefiderocol Resistance AccessWire
19-Nov-2024 CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary AccessWire
19-Nov-2024 Protagonist Therapeutics to Host Conference Call to Announce an Oral Peptide IL-17 Antagonist Development Candidate AccessWire
19-Nov-2024 Bionoid Pharma, Inc. Launches Enhanced Supplements Ltd. to Drive Strategic E-Commerce Expansion AccessWire
19-Nov-2024 Interactive Strength Inc. (Nasdaq:TRNR) Drives CLMBR Growth in Saudi Arabia With Multiple Installations Across Armah Sports Group's B_FIT brand AccessWire
19-Nov-2024 Adnexus Biotechnologies Inc. Appoints Dr. Hiroshi Ohrui to Scientific Advisory Board AccessWire
19-Nov-2024 NANOPRO UNVEILED: NANOPRO REVOLUTIONIZES 2PP 3D PRINTING WITH INDUSTRIAL-SCALE MICROPART PRODUCTION SERVICE UpNano GmbH
19-Nov-2024 Modus Therapeutics Receives Approval to Initiate a Phase IIa Clinical Trial for Chronic Kidney Disease (CKD) Modus Therapeutics
19-Nov-2024 PHIOGEN announces collaboration with Live UTI Free to drive patient-focused clinical trials PHIOGEN
19-Nov-2024 Resolution Therapeutics Announces Approval of Clinical Trial Application by AEMPS to Expand Phase 1/2 EMERALD Study of RTX001 into Spain Resolution Therapeutics
19-Nov-2024 Women’s Health Company Freya Biosciences Announces Key $10.4 Million Strategic Investment Freya Biosciences
19-Nov-2024 Theolytics Doses First Patient in Phase I/IIa Trial of THEO-260 in Ovarian Cancer Theolytics
19-Nov-2024 Cytomos secures £5M to scale up production of cell-analysis technology Cytomos